Relugolix is an orally available, non-peptide gonadotropin-releasing hormone (GnRH or luteinizing hormone-releasing hormone (LHRH)) antagonist, with potential antineoplastic activity.
Molecular Weight:
623.6
Purity:
>98% (HPLC)
CAS Number:
[737789-87-6]
Formula:
C29H27F2N7O5S
Target:
GNRHR
* VAT and and shipping costs not included. Errors and price changes excepted